Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT00177268
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blood draw, skin biopsy or urine collection — OTHER
    Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.

Study Details

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Key Dates

Start date
Oct 31, 2004
Status verified
Dec 2025
Primary completion
Jan 31, 2030
Completion
Jan 31, 2032

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: CTCL, atopic dermatitis, eczema
    Those subjects with cutaneous t-cell lymphoma and Sezary syndrome, atopic dermatitis, or eczema may participate as appropriate with the potential for blood, tissue or urine sampling.

Primary Outcome Measure

Proteomics of Cutaneous T-cell lymphoma [ Time Frame: Ongoing ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Pittsburgh Medical CenterPittsburghPennsylvania15213
Charity L Ruhl, LPN
[email protected]
4126472013
Oleg Akilov, MD, PhD
[email protected]
412-647-4200
Louis Falo, M.D., Ph.D. (SUB_INVESTIGATOR)
Patrizia Fuschiotti, PhD (SUB_INVESTIGATOR)
Hassane Zarour, MD (SUB_INVESTIGATOR)
Oleg E. Akilov, MD, Ph.D (PRINCIPAL_INVESTIGATOR)
Nicolena Verardi, PA-C (SUB_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
University of Pittsburgh Medical Center· Pittsburgh, PA

Related Studies